OverviewChartNewsTraderScreen

Morgan Stanley Call 300 PGR 20.09.../  DE000MG0BD68  /

Stuttgart
6/25/2024  11:53:41 AM Chg.-0.014 Bid3:53:44 PM Ask3:53:44 PM Underlying Strike price Expiration date Option type
0.134EUR -9.46% 0.147
Bid Size: 40,000		 0.160
Ask Size: 40,000		 Progressive Corporat... 300.00 USD 9/20/2024 Call
GlobeNewswire 2:30 PM Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire 2:00 PM AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 1:30 PM Zevra Therapeutics Expands Executive Leadership Team
GlobeNewswire 1:30 PM Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical D...
GlobeNewswire 1:00 PM Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren
GlobeNewswire 12:15 PM Fujifilm Launches 128-Slice Computed Tomography System, FCT iStream, with Vision Modeling Iterative ...
GlobeNewswire 12:05 PM Lulus Expands Footwear Offering By Welcoming Vans Into All-New “Lulus Loves” Capsule
GlobeNewswire 6/24 Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporat...
GlobeNewswire 6/24 NBME continues to be a Great Place To Work®
GlobeNewswire 6/24 Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire 6/24 4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire 6/24 Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire 6/19 Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 6/18 Afamelanotide in fair-skinned Parkinson’s patients
GlobeNewswire 6/14 Progressive Reports May 2024 Results
GlobeNewswire 6/13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire 6/12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire 6/12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 6/11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire 6/11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire 6/11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire 6/10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire 6/10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
TeleTrader 6/9 EP updated results, EPP with 189 seats
TeleTrader 6/9 EPP's Weber claims party victory in EP election